New hope for Tough-to-Treat colorectal cancer: drug targets specific protein
NCT ID NCT06614192
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This phase 3 trial tests two different doses of an investigational drug called telisotuzumab adizutecan in about 74 adults with metastatic colorectal cancer that has stopped responding to standard treatments and whose tumors have a specific protein (c-Met). The drug is given by IV infusion. Researchers will monitor side effects, tumor shrinkage, and overall survival to find the best dose.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
telisotuzumab adizutecan (ABBV-400)
What this could lead to
If successful, this could provide a new treatment option for people with advanced colorectal cancer that has not responded to other therapies.
What could go wrong
This is an early-stage dose-finding study with only 74 participants, so results may not apply to all patients. The drug may cause side effects and may not shrink tumors or extend survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC COLORECTAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AdventHealth Orlando /ID# 267970
Orlando, Florida, 32803, United States
-
Aichi Cancer Center /ID# 268237
Nagoya, Aichi-ken, 464-8681, Japan
-
Asan Medical Center /ID# 268717
Seoul, Seoul Teugbyeolsi, 05505, South Korea
-
Assuta Medical Center - Tel Aviv /ID# 267745
Tel Aviv, Tel Aviv, 6789140, Israel
-
Avera Cancer Institute - Sioux Falls /ID# 268074
Sioux Falls, South Dakota, 57105, United States
-
Changhua Christian Hospital /ID# 270464
Changhua City, Changhua County, 50006, Taiwan
-
China Medical University Hospital /ID# 267631
Taichung, 40447, Taiwan
-
City of Hope - Orange County Lennar Foundation Cancer Center /ID# 270655
Irvine, California, 92618, United States
-
City of Hope National Medical Center /ID# 267875
Duarte, California, 91010, United States
-
Community Cancer Center North /ID# 267965
Indianapolis, Indiana, 46250, United States
-
Duke University Medical Center /ID# 267966
Durham, North Carolina, 27710, United States
-
Hadassah Medical Center-Hebrew University /ID# 267579
Jerusalem, 91120, Israel
-
Hattiesburg Clinic /ID# 267860
Hattiesburg, Mississippi, 39401, United States
-
Hope And Healing Cancer Services /ID# 268541
Hinsdale, Illinois, 60521, United States
-
Intermountain Health St. Vincent Regional Hospital - Cancer Centers of Montana /ID# 268185
Billings, Montana, 59102, United States
-
Kaohsiung Chang Gung Memorial Hospital /ID# 267638
Kaohsiung City, 833, Taiwan
-
Kaohsiung Medical University Chung-Ho Memorial Hospital /ID# 267635
Kaohsiung City, 807, Taiwan
-
Linkou Chang Gung Memorial Hospital /ID# 267637
Taoyuan City, 333, Taiwan
-
Lutheran Medical Center- Cancer Centers of Colorado /ID# 268175
Golden, Colorado, 80401, United States
-
Mater Hospital Brisbane /ID# 268360
South Brisbane, Queensland, 4101, Australia
-
Millennium Physicians /ID# 268400
Houston, Texas, 77090, United States
-
National Cancer Center Hospital /ID# 268713
Chuo-Ku, Tokyo, 104-0045, Japan
-
National Cancer Center Hospital East /ID# 268236
Kashiwa-shi, Chiba, 277-8577, Japan
-
National Cheng Kung University Hospital /ID# 270468
Tainan, 704, Taiwan
-
National Taiwan University Hospital /ID# 267627
Taipei, 100, Taiwan
-
Northwestern Medicine - Northwestern Memorial Hospital /ID# 268610
Chicago, Illinois, 60611, United States
-
Pan American Center for Oncology Trials - Rio Piedras /ID# 267888
Rio Piedras, 00935, Puerto Rico
-
Rabin Medical Center. /ID# 267740
Petah Tikva, Central District, 4941492, Israel
-
Rambam Health Care Campus- Haifa /ID# 267739
Haifa, 3109601, Israel
-
Rutgers Cancer Institute of New Jersey /ID# 268056
New Brunswick, New Jersey, 08901, United States
-
Saitama Prefectural Cancer Center /ID# 268706
Kitaadachi-gun, Saitama, 362-0806, Japan
-
Samsung Medical Center /ID# 268720
Seoul, Seoul Teugbyeolsi, 06351, South Korea
-
Seoul National University Bundang Hospital /ID# 268592
Seongnam-si, Gyeonggido, 13620, South Korea
-
Seoul National University Hospital /ID# 268719
Seoul, Seoul Teugbyeolsi, 03080, South Korea
-
Springfield Clinic - First /ID# 268666
Springfield, Illinois, 62702, United States
-
St. Luke's Cancer Institute: Boise /ID# 268095
Boise, Idaho, 83712, United States
-
Taichung Veterans General Hospital /ID# 270467
Taichung, 407, Taiwan
-
Taipei Veterans General Hospital /ID# 267628
Taipei, 112, Taiwan
-
Tel Aviv Sourasky Medical Center /ID# 267578
Tel Aviv, Tel Aviv, 6423906, Israel
-
The Chaim Sheba Medical Center /ID# 267741
Ramat Gan, Tel Aviv, 5265601, Israel
-
The University of Osaka Hospital /ID# 268743
Suita-shi, Osaka, 565-0871, Japan
-
The University of Texas MD Anderson Cancer Center /ID# 268098
Houston, Texas, 77030, United States
-
USC Norris Comprehensive Cancer Center /ID# 268131
Los Angeles, California, 90033, United States
-
University of North Carolina Medical Center /ID# 266879
Chapel Hill, North Carolina, 27514, United States
-
University of Texas - Southwestern Medical Center /ID# 268241
Dallas, Texas, 75235, United States
-
University of Virginia /ID# 268108
Charlottesville, Virginia, 22908, United States
-
Washington University /ID# 267872
St Louis, Missouri, 63110, United States
-
West Cancer Center and Research Institute - Germantown /ID# 268619
Germantown, Tennessee, 38138, United States
-
Winship Cancer Institute of Emory University /ID# 266884
Atlanta, Georgia, 30322, United States
-
Yale University School of Medicine /ID# 269125
New Haven, Connecticut, 06510, United States
-
Yonsei University Health System Severance Hospital /ID# 268718
Seoul, Seoul Teugbyeolsi, 03722, South Korea